Assertio Holdings, Inc. (ASRT)
NASDAQ: ASRT · IEX Real-Time Price · USD
-0.055 (-3.18%)
Jul 12, 2024, 1:08 PM EDT - Market open

Company Description

Assertio Holdings, Inc., a commercial pharmaceutical company, provides various products to patients in the United States.

Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis.

It also provides Sympazan, a benzodiazepine for the adjunctive treatment of seizures related with lennox-gastaut syndrome in patients aged two years of age or older; CAMBIA, a non steroidal anti inflammatory drug (NSAID) for the treatment of migraine pain, nausea, photophobia, and phonophobia; Zipsor, a NSAID for relief of mild to moderate pain in adults; SPRIX, a NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level; Otrexup, a single-dose auto-injector containing a prescription medicine and methotrexate that is used to treat patients with severe, active rheumatoid arthritis, and active polyarticular juvenile idiopathic arthritis, as well as treat adult with severe, recalcitrant, and disabling psoriasis; and ROLVEDON, a long-acting granulocyte colony-stimulating factor that is indicated to decrease the incidence of infection caused by febrile neutropenia.

The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020.

Assertio Holdings, Inc. was incorporated in 2020 and is headquartered in Lake Forest, Illinois.

Assertio Holdings, Inc.
Assertio Holdings logo
Country United States
Founded 1995
IPO Date Nov 5, 1997
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 53
CEO Brendan P. O'Grady

Contact Details

100 South Saunders Rd, Suite 300
Lake Forest, Illinois 60045
United States
Phone (224) 419-7106

Stock Details

Ticker Symbol ASRT
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001005201
CUSIP Number 04546C205
ISIN Number US04546C2052
Employer ID 94-3229046
SIC Code 2834

Key Executives

Name Position
Heather L. Mason Interim Chief Executive Officer and Director
Ajay Patel Senior Vice President and Chief Financial Officer
Paul Schwichtenberg Senior Vice President and Chief Commercial Officer
Bill Iskos Senior Vice President of Operations
Molly Dir Senior Vice President of Human Resources and Administration ?
Sam Schlessinger Senior Vice President and General Counsel
Dr. Howard J. Franklin M.B.A., M.D. Senior Vice President of Medical

Latest SEC Filings

Date Type Title
Feb 12, 2021 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Jun 18, 2020 15-12B Securities registration termination
May 22, 2020 8-K Current Report
May 19, 2020 25-NSE Filing
May 18, 2020 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
May 11, 2020 10-Q Quarterly Report
May 11, 2020 8-K Current Report
May 11, 2020 425 Filing
Apr 24, 2020 8-K Current Report
Apr 21, 2020 8-K Current Report